President and Chief Executive Officer MD/Ph.D.
His recent research topic was in Automated assessment of the substantia nigra on susceptibility map-weighted imaging using deep convolutional neural networks for diagnosis of Idiopathic Parkinson’s disease, which has been published in Parkinsonism and Related Disorders (VOLUME 85, P84-90, APRIL 01, 2021).
Director of IP, Patent Attorney
He worked as a sales and marketing representative for JW medical and was a head of marketing at Samsung Madison, a global leading medical device company.
He is also the first generation to introduce PACS in Korea as the vice president of Infinitt Healthcare.
He graduated from Korea University’s Graduate School of Computer information and Communication.